查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1886491

傷口護理生物製劑市場－全球產業規模、佔有率、趨勢、機會和預測，按產品、傷口類型、最終用戶、地區和競爭格局分類，2020-2030年預測

Wound Care Biologics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Wound Type, By End User, By Region, and By Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球傷口護理生物製劑市場規模為21.7億美元，預計2030年將以6.19%的複合年成長率成長至31.1億美元。傷口護理生物製劑是源自活體生物或其成分的先進治療產品，旨在增強人體自身的癒合機制，促進各種傷口和組織損傷的組織再生和修復。推動該市場成長的關鍵因素包括全球慢性傷口盛行率的不斷上升，尤其是與人口老化和糖尿病等疾病相關的慢性傷口。

市場概覽
預測期 2026-2030
市場規模：2024年 21.7億美元
市場規模：2030年 31.1億美元
複合年成長率：2025-2030年 6.19%
成長最快的細分市場 潰瘍
最大的市場 北美洲

主要市場促進因素

全球慢性及急性傷口發生率的不斷上升，是全球傷口護理生物製劑市場的主要需求促進因素。糖尿病足潰瘍、壓瘡和靜脈性腿部潰瘍等疾病，由於其病理複雜且癒合緩慢，通常需要更高級的干涉措施。

主要市場挑戰

全球傷口護理生物製劑市場成長面臨的一大挑戰是這些先進生物療法的高昂成本。其研發和複雜生產流程中固有的巨額費用直接轉化為高昂的產品價格。

主要市場趨勢

個人化傷口護理生物製劑的出現代表著一個關鍵的市場趨勢，它標誌著治療方式從千篇一律的模式轉向根據個別患者的需求和特定的傷口特徵量身定做的療法。這需要運用先進的診斷技術，例如生物標記分析和基因組分析，來預測治療反應並指導選擇最有效的生物製劑。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球傷口護理生物製劑市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品（生物性皮膚替代品、外用製劑）
    • 依傷口類型（潰瘍、手術和創傷性傷口、燒傷）
    • 按最終使用者（醫院、門診手術中心、燒傷中心、傷口診所）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美傷口護理生物製劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲傷口護理生物製劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區傷口護理生物製劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲傷口護理生物製劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲傷口護理生物製劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球傷口護理生物製劑市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Smith & Nephew Plc
  • Integra LifeSciences Corporation
  • Wright Medical Group NV
  • MiMedx Group, Inc.
  • Vericel Corporation
  • Osiris Therapeutics, Inc.
  • Organogenesis Holdings Inc.
  • Solsys Medical, LLC
  • Lavior Pharma Inc.
  • Marine Polymer Technologies, Inc.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 23800

The Global Wound Care Biologics Market, valued at USD 2.17 Billion in 2024, is projected to experience a CAGR of 6.19% to reach USD 3.11 Billion by 2030. Wound care biologics are advanced therapeutic products derived from living organisms or their components, engineered to augment the body's intrinsic healing mechanisms, facilitating tissue regeneration and repair for various wounds and tissue injuries. Key drivers supporting this market include the increasing global prevalence of chronic wounds, particularly those associated with an aging population and conditions such as diabetes.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.17 Billion
Market Size 2030USD 3.11 Billion
CAGR 2025-20306.19%
Fastest Growing SegmentUlcers
Largest MarketNorth America

Key Market Drivers

The increasing global incidence of chronic and acute wounds represents a fundamental demand driver for the Global Wound Care Biologics Market. Conditions such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers often require advanced interventions due to their complex pathology and delayed healing. The prevalence of these challenging wounds creates a substantial patient population seeking effective therapeutic solutions.

Key Market Challenges

A significant challenge impeding the growth of the Global Wound Care Biologics Market is the elevated cost associated with these advanced biological therapies. The substantial expenses inherent in their research, development, and complex manufacturing processes directly translate into high product pricing. This elevated cost restricts patient access, especially in healthcare systems with stringent budget limitations or where individual out-of-pocket expenses become prohibitive. Furthermore, it introduces considerable complexities in obtaining favorable reimbursement from payers, as these entities often require extensive evidence of superior cost-effectiveness compared to existing, less expensive treatments.

Key Market Trends

The emergence of personalized wound care biologics solutions represents a pivotal market trend, moving away from uniform treatments to therapies tailored to individual patient needs and specific wound characteristics. This involves employing advanced diagnostics, such as biomarker analysis and genomic profiling, to predict therapeutic responses and guide the selection of the most effective biologic agents. This tailored approach aims to enhance treatment efficacy, reduce healing times, and optimize healthcare resource allocation by ensuring appropriate therapy application.

Key Market Players

  • Smith & Nephew Plc
  • Integra LifeSciences Corporation
  • Wright Medical Group N.V.
  • MiMedx Group, Inc.
  • Vericel Corporation
  • Osiris Therapeutics, Inc.
  • Organogenesis Holdings Inc.
  • Solsys Medical, LLC
  • Lavior Pharma Inc.
  • Marine Polymer Technologies, Inc.

Report Scope:

In this report, the Global Wound Care Biologics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Wound Care Biologics Market, By Product:

  • Biologic Skin Substitutes
  • Topical Agents

Wound Care Biologics Market, By Wound Type:

  • Ulcers
  • Surgical and Traumatic Wounds
  • Burns

Wound Care Biologics Market, By End User:

  • Hospitals
  • ASCs
  • Burn Centers
  • Wound Clinics

Wound Care Biologics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Wound Care Biologics Market.

Available Customizations:

Global Wound Care Biologics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Wound Care Biologics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Biologic Skin Substitutes, Topical Agents)
    • 5.2.2. By Wound Type (Ulcers, Surgical and Traumatic Wounds, Burns)
    • 5.2.3. By End User (Hospitals, ASCs, Burn Centers, Wound Clinics)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Wound Care Biologics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Wound Type
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Wound Care Biologics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Wound Type
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Wound Care Biologics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Wound Type
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Wound Care Biologics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Wound Type
        • 6.3.3.2.3. By End User

7. Europe Wound Care Biologics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Wound Type
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Wound Care Biologics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Wound Type
        • 7.3.1.2.3. By End User
    • 7.3.2. France Wound Care Biologics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Wound Type
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Wound Care Biologics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Wound Type
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Wound Care Biologics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Wound Type
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Wound Care Biologics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Wound Type
        • 7.3.5.2.3. By End User

8. Asia Pacific Wound Care Biologics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Wound Type
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Wound Care Biologics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Wound Type
        • 8.3.1.2.3. By End User
    • 8.3.2. India Wound Care Biologics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Wound Type
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Wound Care Biologics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Wound Type
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Wound Care Biologics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Wound Type
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Wound Care Biologics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Wound Type
        • 8.3.5.2.3. By End User

9. Middle East & Africa Wound Care Biologics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Wound Type
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Wound Care Biologics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Wound Type
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Wound Care Biologics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Wound Type
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Wound Care Biologics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Wound Type
        • 9.3.3.2.3. By End User

10. South America Wound Care Biologics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Wound Type
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Wound Care Biologics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Wound Type
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Wound Care Biologics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Wound Type
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Wound Care Biologics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Wound Type
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Wound Care Biologics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Smith & Nephew Plc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Integra LifeSciences Corporation
  • 15.3. Wright Medical Group N.V.
  • 15.4. MiMedx Group, Inc.
  • 15.5. Vericel Corporation
  • 15.6. Osiris Therapeutics, Inc.
  • 15.7. Organogenesis Holdings Inc.
  • 15.8. Solsys Medical, LLC
  • 15.9. Lavior Pharma Inc.
  • 15.10. Marine Polymer Technologies, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer